Centre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, T6G 2M8, Canada.
Centre for Neuroscience, University of Alberta, Edmonton, Alberta, T6G 2M8, Canada.
Mol Neurobiol. 2018 Jul;55(7):5757-5766. doi: 10.1007/s12035-017-0799-5. Epub 2017 Oct 19.
Amyloid precursor protein (APP) is cleaved by a set of proteases including α-/β-/γ- and recently identified η-secretases, generating C-terminal fragments (CTFs) of varying lengths and amyloid β (Aβ) peptides, which are considered to play a pivotal role in Alzheimer's disease (AD) pathogenesis. Cellular cholesterol content/distribution can regulate the production/clearance of APP metabolites and hence modify AD pathology. To determine the functional relation between endosomal-lysosomal (EL) cholesterol sequestration and APP metabolism, we used our recently developed mouse N2a-ANPC cells that overexpress Swedish mutant human APP in the absence of cholesterol-trafficking Niemann-Pick type C1 (Npc1) protein. Here, we report that neither increased levels nor EL cholesterol sequestration altered APP holoprotein levels but caused the intracellular accumulation of APP α-/β-/η-CTFs and Aβ peptides. The levels of APP-cleaved products increased as a function of extracellular serum concentration in N2a-ANPC cells, which are more vulnerable to death than the control cells. Additionally, we show that pH of the lysosomal vesicles in N2a-ANPC cells shifted to a less acidic range with increasing serum concentrations, thus making them less efficient functionally. Interestingly, the addition of cholesterol to the culture media not only increased the levels of cellular cholesterol and APP-cleaved products but also rendered the cells more vulnerable to toxicity. Collectively, our results suggest that extracellular cholesterol concentration in serum under conditions of Npc1 deficiency can influence intracellular cholesterol content/distribution and lysosomal efficacy, triggering the accumulation of toxic APP-cleaved products, eventually leading to cell death.
淀粉样前体蛋白(APP)被一系列蛋白酶切割,包括 α-/β-/γ-和最近发现的 η-分泌酶,生成具有不同长度的 C 端片段(CTFs)和淀粉样 β(Aβ)肽,这些被认为在阿尔茨海默病(AD)发病机制中起关键作用。细胞内胆固醇含量/分布可以调节 APP 代谢物的产生/清除,从而改变 AD 病理。为了确定内体-溶酶体(EL)胆固醇隔离与 APP 代谢之间的功能关系,我们使用了最近开发的 N2a-ANPC 细胞,该细胞在没有胆固醇转运尼曼-皮克 C1(NPC1)蛋白的情况下过表达瑞典突变型人 APP。在这里,我们报告说,增加水平或 EL 胆固醇隔离不会改变 APP 全蛋白水平,但会导致 APP α-/β-/η-CTFs 和 Aβ 肽的细胞内积累。在 N2a-ANPC 细胞中,APP 切割产物的水平随着细胞外血清浓度的增加而增加,这些细胞比对照细胞更容易死亡。此外,我们表明,N2a-ANPC 细胞溶酶体囊泡的 pH 值随着血清浓度的增加向更酸性的范围转移,从而使它们的功能效率降低。有趣的是,向培养基中添加胆固醇不仅增加了细胞内胆固醇和 APP 切割产物的水平,而且使细胞更容易受到毒性的影响。总之,我们的研究结果表明,NPC1 缺乏条件下血清中的细胞外胆固醇浓度可以影响细胞内胆固醇含量/分布和溶酶体功效,触发有毒的 APP 切割产物的积累,最终导致细胞死亡。